Mounjaro 5mg
$465.00 – $8,950.00
Additional information
Pack Size | 1 Pen, 10 Pens, 20 Pens, 3 Pens, 5 Pens |
---|
Mounjaro 5mg (Tirzepatide) is an FDA-approved injectable medication for type 2 diabetes management. Developed by Eli Lilly and Company, it is a dual GLP-1 and GIP receptor agonist that effectively controls blood sugar levels while supporting weight management. This once-weekly injection helps improve insulin sensitivity and glucose metabolism, offering a breakthrough in diabetes care.